Latest Releases
U.S. Senator Tina Smith Joins Elizabeth Warren, Banking Committee Democrats in Pressing SEC Chair to Require Disclosure of Corporate Lobbying Expenditures
Washington, D.C. — Today, U.S. Senators Tina Smith (D – Minn.), Sherrod Brown (D-Ohio.), Jon Tester (D-Mont.) and John Fetterman (D-Pa.) signed onto a letter led by Senator Elizabeth Warren (D – Mass.) urging Gary Gensler, Chair of the U.S. Securities and Exchange Commission (SEC), to create new rules requiring public companies to disclose their spending on lobbying efforts. Public companies are not currently required to report information on the details of their lobbying to the SEC even as corporate lobbying expenditures reach record highs. “In 2022, total federal lobbying expenditures reached $4.1 billion – the highest since 2010. Amazon and Meta spent almost $20 million each to influence decision-making in Congress and across government agencies, while the U.S. Chamber of Commerce – which counts companies like JPMorgan Chase, Alphabet, and Chevron among its members – spent $79.4 million,” wrote the senators. “While these figures are staggering, they provide little insight into the interests that companies spend millions each year to advance. This lack of transparency erodes the ability of everyday investors to make informed decisions about where to invest their money – and where their money goes once they have invested.” Specifically, the senators are requesting that such rules require disclosure of lobbying strategy, the total amount of direct or indirect contributions to registered state and federal lobbyists and any material risks related to or arising from lobbying strategies and expenditures. The senators requested the SEC provide them with details on their plans to develop and issue such rules no later than
U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing
WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S. The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals. “Ensuring that
U.S. Senators Tina Smith and Tammy Baldwin: ‘We’re Not the Same Person’ in Video on Climate Change
WASHINGTON, DC [08/01/19]— Today in a new video, U.S. Senators Tina Smith (D-Minn.) and Tammy Baldwin (D-Wis.) called for action to protect the Great Lakes from the adverse effects of climate change while establishing their distinct identities. Smith and Baldwin, both members of the Senate Democratic Special Committee on the Climate Crisis, said that the negative effects of climate change on the Great Lakes, such as the increase in average surface water temperatures, pose a threat to public health, the environment, and the economy. Environmental changes in the Great Lakes region create challenges for nearby communities, wildlife populations, and the industries that sustain over
U.S. Senator Tina Smith Leads Bipartisan Effort to Improve Access to Rural Health Care for New and Expecting Moms
WASHINGTON, D.C. [07/31/19]–Today, U.S. Senator Tina Smith (D-Minn.) introduced a bipartisan bill that would help ensure that new and expecting moms living in rural communities get the care they need. Sen. Smith—a member of the Senate Health Committee—said that this is especially a problem in rural areas across Minnesota and the country. Approximately a third of Minnesota’s rural counties don’t have a hospital where women can give birth, and more than half of rural counties nationwide lack hospitals with labor and birthing services. Sen. Smith also noted that the disparity in access to care and worse health outcomes disproportionally affects women of
Sen. Tina Smith Pushes to Help Schools Overcome Teacher Shortages in Minnesota, Across the Country
WASHINGTON D.C [07/31/19]—Today, U.S. Sen. Tina Smith (D-Minn.)—a member of the Senate Education Committee—reintroduced legislation to help schools and districts in Minnesota and across the country hit hard by teacher shortages. Sen. Smith is pushing the legislation because right now there are not enough teachers to meet the demand in all locations and in all fields, resulting in teacher shortages. More than 40 percent of the nation’s small, rural school districts struggle with adequately staffing their schools, and shortages are most acute in certain subject areas. There is a growing need for STEM, foreign language, and special education teachers. Additionally, there is a severe lack of racial diversity—nationwide teachers of color compromise only 18 percent of
TOMORROW: U.S. Senator Tina Smith Joins Patients, Fellow Lawmakers, and Advocates To Demand Bold Action to Bring Down Drug Prices
WASHINGTON, DC [07/25/19]—Tomorrow, U.S. Senator Tina Smith (D-Minn.) and patients from across the country will gather in front of the U.S. Capitol to demand bold action to lower prescription drug prices. Sen. Smith will be joined by fellow lawmakers, as well as advocates, to highlight the need for Congress to address this pressing issue. The press conference will occur right before the House Committee on Oversight and Reform holds a hearing with patients, titled “The Patient Perspective: The Devastating Impacts of Skyrocketing Drug Prices on American Families.” It also coincides with the Center for Popular Democracy’s patient bus trip to
English